The drug company that prospered without creating any drugs The new drug looked so promising — except for that one warning sign. Tribune News Service · Apr 19, 2023
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own Horizon grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices. Fortune · Apr 13, 2023